Preferred Label : HCV Antigen Therapeutic Bivalent Vaccine V5;
NCIt definition : An orally bioavailable, therapeutic bivalent vaccine composed of heat- and chemical-inactivated
hepatitis C virus (HCV) antigens derived from the blood of HCV-infected carriers,
with potential immunomodulating activity. Upon oral administration of the HCV antigen
therapeutic bivalent vaccine V5, the HCV antigens may stimulate the host immune system
to mount an immune response against HCV-infected cells, thereby preventing further
HCV-infection and HCV-induced liver injury.;
Drug name : V-5 Immunitor;
Origin ID : C118361;
UMLS CUI : C3898996;
Semantic type(s)
- concept_is_in_subset
